{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-25-000088","form_type":"8-K","ticker":"CHE","cik":"0000019584","company_name":"CHEMED CORP","filed_at":"2025-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.567649+00:00","generated_at":"2026-05-23T08:25:55.534276+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Chemed Q1 revenue up 9.8% to $646.9M; GAAP EPS $4.86, adjusted $5.63","bullets":["VITAS net revenue +15.1% to $407.4M; ADC 22,244 (+13.1%); adjusted EBITDA $70.3M (+15.9%).","Roto-Rooter revenue +1.8% to $239.5M but adjusted EBITDA -2.4% to $59.2M; margin down 108 bps.","Cash $173.9M; no debt; repurchased 50k shares for $29.8M at $595.15/share.","Covenant Health contributed ~$12M revenue, $2.6M EBITDA in Q1.","Full-year guidance update deferred to Q2 earnings release in June."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-25-000088","json":"https://secwatch.observer/filing/0001562762-25-000088.json","markdown":"https://secwatch.observer/filing/0001562762-25-000088.md","text":"https://secwatch.observer/filing/0001562762-25-000088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/19584/000156276225000088/0001562762-25-000088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/19584/000156276225000088/che-20250423x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T08:25:55.534276+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}